Engineered two-dimensional nanomaterials based diagnostics integrated with internet of medical things (IoMT) for COVID-19

MA Sadique, S Yadav, R Khan… - Chemical Society …, 2024 - pubs.rsc.org
More than four years have passed since an inimitable coronavirus disease (COVID-19)
pandemic hit the globe in 2019 after an uncontrolled transmission of the severe acute …

Impact of vaccination and non-pharmacological interventions on COVID-19: a review of simulation modeling studies in Asia

K Thakkar, JR Spinardi, J Yang, MH Kyaw… - Frontiers in Public …, 2023 - frontiersin.org
Introduction Epidemiological modeling is widely used to offer insights into the COVID-19
pandemic situation in Asia. We reviewed published computational (mathematical/simulation) …

Durable cross-protective neutralizing antibody responses elicited by lipid nanoparticle-formulated SARS-CoV-2 mRNA vaccines

KH Bae, B Shunmuganathan, L Zhang, A Lim, R Gupta… - npj Vaccines, 2024 - nature.com
The advent of SARS-CoV-2 variants with defined mutations that augment pathogenicity
and/or increase immune evasiveness continues to stimulate global efforts to improve …

Updated considerations for the immunopharmacological aspects of the “talented mRNA vaccines”

C Perrotta, C Fenizia, C Carnovale, M Pozzi… - Vaccines, 2023 - mdpi.com
Messenger RNA (mRNA) vaccines belong to a new class of medications, RNA therapeutics,
including both coding and non-coding RNAs. The use of mRNA as a therapy is based on the …

Genomic insights into mRNA COVID-19 vaccines efficacy: Linking genetic polymorphisms to waning immunity

MJ Hsieh, PH Tsai, PH Chiang, ZK Kao… - Human Vaccines & …, 2024 - Taylor & Francis
Genetic polymorphisms have been linked to the differential waning of vaccine-induced
immunity against COVID-19 following vaccination. Despite this, evidence on the …

Co-administration of recombinant BCG and SARS-CoV-2 proteins leads to robust antiviral immunity

MA Ramírez, RA Loaiza, Y Martínez-Balboa… - Vaccine, 2024 - Elsevier
SARS-CoV-2 is the causative virus of COVID-19, which has been responsible for millions of
deaths worldwide since its discovery. After its emergence, several variants have been …

COVID-19: vaccination, therapeutics and a review of the science and public health

SK Shah, K Bhandari, A Shah… - Annals of Medicine and …, 2024 - journals.lww.com
COVID-19, stemming from the SARS-CoV-2 virus, has initiated a worldwide respiratory
pandemic. Remarkable headway has been made in the realm of vaccination, as nearly …

Nanoparticle-neutrophils interactions for autoimmune regulation

D Kupor, ML Felder, S Kodikalla, X Chu… - Advanced Drug Delivery …, 2024 - Elsevier
Neutrophils play an essential role as 'first responders' in the immune response,
necessitating many immune-modulating capabilities. Chronic, unresolved inflammation is …

[HTML][HTML] HTLV-1 vaccination Landscape: Current developments and challenges

A Letafati, M Bahari, OS Ardekani, NN Jazi, A Nikzad… - Vaccine: X, 2024 - Elsevier
Human T-lymphotropic virus type 1 (HTLV-1) is a retrovirus that is distinguished for its
correlation to myelopathy/tropical spastic paraparesis (HAM/TSP) and adult T-cell …

Bacterial biopolymers in tissue engineering and regenerative medicine; current applications and future perspective

B Bakhshandeh, F Mohammadipanah… - Biocatalysis and …, 2023 - Elsevier
Tissue engineering (TE), a fast-growing field of regenerative medicine, has been designed
to replace diseased or damaged tissues. As cellular factories, microbes produce a wide …